Video
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.
Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.
Alessio Fasano gives an overview of the IHMC Congress to be held in Rome, 22-25 June.
Silvia Barbaresi, molecular biologist, researcher and nutritionist at Ghent Univerity, discusses how sports and physical activity in general impact on gut microbiota composition.
Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, discusses how celiac disease could become a model to study the link between gut microbiome and disease pathogenesis.
Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the future of microbiota modulation, with a focus on Microbial Therapeutics.
Francisco Guarner, from Centro Médico Teknon (Barcelona, Spain), talks about the recent update of the WGO’s Probiotics and prebiotics guidelines.
Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, talks about the mechanistic link between gut microbiome and disease pathogenesis and the impact on the future clinical practice.
Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the key determinants of success of FMT in the treatment of C. Difficile infections and other conditions.
Vegim Zhaku, from Tetovo University Faculty of Medicine, Macedonia, discussed the case of a male patient with palpitations, shortness of breath, epigastric discomfort and flatulence.
